Skip to the page

Data / Form D filings / OcuTerra Therapeutics, Inc.

OcuTerra Therapeutics, Inc.: Form D filings

OcuTerra Therapeutics, Inc., a company in Boston, MA, filed 5 Form D notices with the SEC between 2019 and 2024. The latest, on February 22, 2024, reports $25.6 million sold of a $25.6 million offering to 279 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
85 E. INDIA ROW, SUITE 21G, Boston, MA, 02110
Phone
(339) 234-1333
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1641226

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 22, 2024Amendment$25,625,440$25,625,440279Dec 14, 2023sec.gov
Dec 22, 2023New notice$30,000,000$6,658,827$23,341,17384Dec 14, 2023sec.gov
Aug 24, 2021Amendment$50,000,000$31,525,965$18,474,035226Apr 27, 2021sec.gov
May 11, 2021New notice$40,000,000$14,609,408$25,390,59287Apr 27, 2021sec.gov
Sep 26, 2019New notice$1,500,000$0$1,500,0000Yet to occursec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Kerrie BradyExecutive Officer, Director
D. Scott EdwardsExecutive Officer
Robin H. SteeleDirector
David J. TanzerExecutive Officer
William H. KosterDirector
Bruce H. FailingDirector
Barbara H. RyanDirector
Brenton Scott SaundersDirector
Robert H. RuffoloDirector
William Scott SteinkraussExecutive Officer

Other companies in Massachusetts that filed recently

Every Form D from the week of Feb 19, 2024 · All recent filings in Massachusetts · All recent Other filings

Read from SEC EDGAR. Amount sold is what OcuTerra Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.